195 related articles for article (PubMed ID: 28263291)
1. Iron suppresses erythropoietin expression via oxidative stress-dependent hypoxia-inducible factor-2 alpha inactivation.
Oshima K; Ikeda Y; Horinouchi Y; Watanabe H; Hamano H; Kihira Y; Kishi S; Izawa-Ishizawa Y; Miyamoto L; Hirayama T; Nagasawa H; Ishizawa K; Tsuchiya K; Tamaki T
Lab Invest; 2017 May; 97(5):555-566. PubMed ID: 28263291
[TBL] [Abstract][Full Text] [Related]
2. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
[TBL] [Abstract][Full Text] [Related]
3. Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.
Kapitsinou PP; Liu Q; Unger TL; Rha J; Davidoff O; Keith B; Epstein JA; Moores SL; Erickson-Miller CL; Haase VH
Blood; 2010 Oct; 116(16):3039-48. PubMed ID: 20628150
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of the sensory and regulatory pathways controlling cellular iron metabolism in unilateral obstructive nephropathy.
Votava JA; Reese SR; Deck KM; Nizzi CP; Anderson SA; Djamali A; Eisenstein RS
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F89-F103. PubMed ID: 34843656
[TBL] [Abstract][Full Text] [Related]
5. Iron attenuates erythropoietin production by decreasing hypoxia-inducible transcription factor 2α concentrations in renal interstitial fibroblasts.
Suzuki N; Matsuo-Tezuka Y; Sasaki Y; Sato K; Miyauchi K; Kato K; Saito S; Shimonaka Y; Hirata M; Yamamoto M
Kidney Int; 2018 Nov; 94(5):900-911. PubMed ID: 30245128
[TBL] [Abstract][Full Text] [Related]
6. S1P Stimulates Erythropoietin Production in Mouse Renal Interstitial Fibroblasts by S1P
Hafizi R; Imeri F; Wenger RH; Huwiler A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502385
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 decreases erythropoietin production through repressing hypoxia-inducible factor 2α in erythropoietin-producing cells.
Shih HM; Pan SY; Wu CJ; Chou YH; Chen CY; Chang FC; Chen YT; Chiang WC; Tsai HC; Chen YM; Lin SL
J Biomed Sci; 2021 Nov; 28(1):73. PubMed ID: 34724959
[TBL] [Abstract][Full Text] [Related]
8. Sphk1 and Sphk2 Differentially Regulate Erythropoietin Synthesis in Mouse Renal Interstitial Fibroblast-like Cells.
Hafizi R; Imeri F; Stepanovska Tanturovska B; Manaila R; Schwalm S; Trautmann S; Wenger RH; Pfeilschifter J; Huwiler A
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682566
[TBL] [Abstract][Full Text] [Related]
9. Palmitate deranges erythropoietin production via transcription factor ATF4 activation of unfolded protein response.
Anusornvongchai T; Nangaku M; Jao TM; Wu CH; Ishimoto Y; Maekawa H; Tanaka T; Shimizu A; Yamamoto M; Suzuki N; Sassa R; Inagi R
Kidney Int; 2018 Sep; 94(3):536-550. PubMed ID: 29887316
[TBL] [Abstract][Full Text] [Related]
10. The relationship of erythropoietin overexpression with von Hippel-Lindau tumour suppressor gene mutations between hypoxia-inducible factor-1α and -2α in sporadic clear cell renal carcinoma.
Gong K; Zhang N; Zhang K; Na Y
Int J Mol Med; 2010 Dec; 26(6):907-12. PubMed ID: 21042786
[TBL] [Abstract][Full Text] [Related]
11. The effect of hemin-induced oxidative stress on erythropoietin production in HepG2 cells.
Nishimura K; Tokida M; Katsuyama H; Nakagawa H; Matsuo S
Cell Biol Int; 2014 Nov; 38(11):1321-9. PubMed ID: 24962609
[TBL] [Abstract][Full Text] [Related]
12. Effects of PHD and HSP90 on erythropoietin production in yak (Bos grunniens) renal interstitial fibroblast-like cells under hypoxia.
Cui Y; Li H; Yu SJ; Afedo SY; Bai XF
J Mol Histol; 2022 Apr; 53(2):395-411. PubMed ID: 35084636
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokine tumor necrosis factor α suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2α.
Nagaya Y; Aoyama M; Tamura T; Kakita H; Kato S; Hida H; Saitoh S; Asai K
Eur J Neurosci; 2014 Dec; 40(11):3620-6. PubMed ID: 25283246
[TBL] [Abstract][Full Text] [Related]
14. TP0463518, a Novel Prolyl Hydroxylase Inhibitor, Specifically Induces Erythropoietin Production in the Liver.
Kato S; Ochiai N; Takano H; Io F; Takayama N; Koretsune H; Kunioka EI; Uchida S; Yamamoto K
J Pharmacol Exp Ther; 2019 Dec; 371(3):675-683. PubMed ID: 31585986
[TBL] [Abstract][Full Text] [Related]
15. Activation of aryl hydrocarbon receptor mediates suppression of hypoxia-inducible factor-dependent erythropoietin expression by indoxyl sulfate.
Asai H; Hirata J; Hirano A; Hirai K; Seki S; Watanabe-Akanuma M
Am J Physiol Cell Physiol; 2016 Jan; 310(2):C142-50. PubMed ID: 26561638
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis.
Liu Q; Davidoff O; Niss K; Haase VH
J Clin Invest; 2012 Dec; 122(12):4635-44. PubMed ID: 23114598
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia and the HIF system in kidney disease.
Nangaku M; Eckardt KU
J Mol Med (Berl); 2007 Dec; 85(12):1325-30. PubMed ID: 18026918
[TBL] [Abstract][Full Text] [Related]
18. Endoplasmic reticulum stress signal impairs erythropoietin production: a role for ATF4.
Chiang CK; Nangaku M; Tanaka T; Iwawaki T; Inagi R
Am J Physiol Cell Physiol; 2013 Feb; 304(4):C342-53. PubMed ID: 23242184
[TBL] [Abstract][Full Text] [Related]
19. The drug-specific properties of hypoxia-inducible factor-prolyl hydroxylase inhibitors in mice reveal a significant contribution of the kidney compared to the liver to erythropoietin induction.
Nakai T; Saigusa D; Kato K; Fukuuchi T; Koshiba S; Yamamoto M; Suzuki N
Life Sci; 2024 Jun; 346():122641. PubMed ID: 38614299
[TBL] [Abstract][Full Text] [Related]
20. The volatile anesthetic isoflurane differentially suppresses the induction of erythropoietin synthesis elicited by acute anemia and systemic hypoxemia in mice in an hypoxia-inducible factor-2-dependent manner.
Kai S; Tanaka T; Matsuyama T; Suzuki K; Hirota K
Eur J Pharmacol; 2014 Jun; 732():43-9. PubMed ID: 24680923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
